BMI Korea
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Evaluate the Safety and Tolerability of a Single-dose Administration of BMI2004 Inj. (NCT05922813) | BMI Korea | 2022-06-30 |
| Treatment of Moderate to Severe Glabellar Lines (BMI2006) (NCT05531968) | BMI Korea | 2021-02-09 |
Track BMI Korea automatically
Every clearance here is in the API, with alerts when new ones post.